Li Y - Search Results

1

Antitumor efficacy of the scFv-based fusion protein and its enediyne-energized analogue directed against epidermal growth factor receptor.

Sheng W, Shang Y, Miao Q, Li Y, Zhen Y. Sheng W, et al. Among authors: li y. Anticancer Drugs. 2012 Apr;23(4):406-16. doi: 10.1097/CAD.0b013e32834f9801. Anticancer Drugs. 2012. PMID: 22205154

2

[Inhibitory effect of lidamycin on growth of colon carcinoma 26 and hepatic metastasis in mice].

Liu XJ, Dai Y, Shang Y, Li Y, Zhen YS. Liu XJ, et al. Among authors: li y. Ai Zheng. 2005 Jun;24(6):641-5. Ai Zheng. 2005. PMID: 15946470 Chinese.

3

A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice.

Zhong G, Zhang S, Li Y, Liu X, Gao R, Miao Q, Zhen Y. Zhong G, et al. Among authors: li y. Cancer Lett. 2010 Sep 1;295(1):124-33. doi: 10.1016/j.canlet.2010.02.020. Epub 2010 Mar 19. Cancer Lett. 2010. PMID: 20303650

4

Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.

Gong JH, Liu XJ, Li Y, Zhen YS. Gong JH, et al. Among authors: li y. Cancer Chemother Pharmacol. 2012 May;69(5):1323-32. doi: 10.1007/s00280-012-1827-9. Epub 2012 Feb 5. Cancer Chemother Pharmacol. 2012. PMID: 22311160

5

An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity.

Zheng YB, Shang BY, Li Y, Zhen YS. Zheng YB, et al. Among authors: li y. Biomed Pharmacother. 2013 Mar;67(2):164-71. doi: 10.1016/j.biopha.2012.10.018. Epub 2012 Nov 19. Biomed Pharmacother. 2013. PMID: 23206754

6

Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis.

Jiang WG, Lu XA, Shang BY, Fu Y, Zhang SH, Zhou D, Li L, Li Y, Luo Y, Zhen YS. Jiang WG, et al. Among authors: li y, li l. BMC Cancer. 2013 Oct 15;13:479. doi: 10.1186/1471-2407-13-479. BMC Cancer. 2013. PMID: 24128285 Free PMC article.

7

Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.

Li XQ, Ouyang ZG, Zhang SH, Liu H, Shang Y, Li Y, Zhen YS. Li XQ, et al. Among authors: li y. Cancer Biol Ther. 2014 Apr;15(4):398-408. doi: 10.4161/cbt.27626. Epub 2014 Jan 14. Cancer Biol Ther. 2014. PMID: 24424202 Free PMC article.

8

A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity.

Zhu D, Wang X, Shang Y, Li Y, Jiang W, Li L, Chen SZ. Zhu D, et al. Among authors: li y, li l. Anticancer Drugs. 2015 Jan;26(1):64-73. doi: 10.1097/CAD.0000000000000160. Anticancer Drugs. 2015. PMID: 25122444

9

Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.

Liu WJ, Liu XJ, Li L, Li Y, Zhang SH, Zhen YS. Liu WJ, et al. Among authors: li y, li l. Cancer Immunol Immunother. 2014 Dec;63(12):1261-72. doi: 10.1007/s00262-014-1604-1. Epub 2014 Aug 28. Cancer Immunol Immunother. 2014. PMID: 25164878 Free PMC article.

10

An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy.

Xu J, Liu XJ, Li L, Zhang SH, Li Y, Gao RJ, Zhen YS. Xu J, et al. Among authors: li y, li l. Oncotarget. 2015 Sep 22;6(28):26322-34. doi: 10.18632/oncotarget.4709. Oncotarget. 2015. PMID: 26314845 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238,929 results

Search Page

Filters